VTP for Low-Grade UTUC, NAC for cN+ Disease

Seth P. Lerner, MD, of Baylor College of Medicine, shares some of the impactful updates in upper tract urothelial carcinoma presented at the AUA 2024 Annual Meeting.

Dr. Lerner chaired a poster session that included efficacy and safety data from the phase 3 ENLIGHTED trial, as well as multiple analyses pertaining to neoadjuvant chemotherapy from the ROBUUST registry.